IBS-C Drugs Market Research Report 2017-2025 | Inkwood Research - PowerPoint PPT Presentation

About This Presentation
Title:

IBS-C Drugs Market Research Report 2017-2025 | Inkwood Research

Description:

The global IBS-C drug market is expected to grow at a CAGR of 6.30% during the forecast period of 2017 – 2025. Some of the primary factors responsible for the growth in the market are the ease of availability of effective drugs in the market, modern dietary habits affecting the health, various psychological factors affecting the irritable bowel syndrome and the opportunity of improved and efficient drugs in the pipeline with many first-in-class molecules – PowerPoint PPT presentation

Number of Views:49

less

Transcript and Presenter's Notes

Title: IBS-C Drugs Market Research Report 2017-2025 | Inkwood Research


1
(No Transcript)
2
GLOBAL IBS-C DRUG MARKET FORECAST 2017-2025
Global IBS-C drug market is expected to grow at
a CAGR of 6.30 during the forecast period of
2017-2025.
3
MARKET DRIVERS
4
MARKET INSIGHTS
?
?
?
The global IBS-C drug market is segmented on the
type of drug and prescription. The Drugs type is
further classified into Linaclotide,
Lubiprostone, Osmotic Laxatives, Stimulant
Laxatives, and others.
Of these, lubiprostone is a highly popular drug
in the market. The market by Prescription type is
further segmented into prescribed drugs and over
the counter drugs.
The distribution channels are further sub-divided
into internet retailing, hypermarkets/supermarkets
, chemists and beauty specialists retailers and
others.
The over the counter drugs are leading this
segment since no prescription from a doctor is
required.
?
The market for global male grooming products is
segmented on the basis of its distribution
channel.
5
REQUEST FREE SAMPLE
Global IBS-C drug market is expected to grow at a
CAGR of 6.30 during the forecast period of
2017-2025.

Inkwood Research
6
REGIONAL INSIGHTS
Asia-Pacific IBS-c drug market Growing at a CAGR
8.85 During the Forecast Period of 2017-2025
Europe IBS-c drug market Growing at a CAGR 5.29
During the Forecast Period of 2017-2025
North American IBS-c drug Market Growing at a
CAGR 6.30 During the Forecast Period of
2017-2025
GET FREE SAMPLE
GET FREE SAMPLE
GET FREE SAMPLE
7
COMPETITIVE INSIGHTS
  • Some of the major players in the global IBS-C
    drug market include
  • Nestle
  • Catalent Pharma Solutions
  • Abbot Laboratories
  • Sucampo Pharmaceuticals
  • Synergy Pharmaceuticals
  • Novartis 

8
ABOUT US
Inkwood Research specializes in syndicated
research reports, customized research reports and
consulting services. We offer market intelligence
studies across a range of industries including
Technology, Chemicals, Materials, Healthcare and
Energy. With 20 years of research experience, we
ensure you efficient deliverables with global and
country industry knowledge and research
expertise. Our analysis covers North South
America, Europe, CEE, CIS, Middle East, Africa
and Asia.
9
CONTACT US
www.inkwoodresearch.com
9
10
Thank you!
_at_Inkwoodresearch
https//www.inkwoodresearch.com
Write a Comment
User Comments (0)
About PowerShow.com